跳至主要内容
临床试验/CTRI/2019/05/019147
CTRI/2019/05/019147已完成未知

To study the incidence and severity of endobronchial bleeding during Transbronchial lung biopsy (TBLB) procedure in patients without known clinical risk factors for increased bleeding: A Prospective observational study. - BRIL Study (Bleeding Risk in Lung Biopsy)

Fluid Research Fund0 个研究点目标入组 289 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
289

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All male and female patients above the age of 18 years presenting to the department of Pulmonary Medicine department of CMC for Transbronchial Lung biopsy

排除标准

  • -Known bleeding diathesis
  • -Pregnant women
  • -Thrombocytopenia
  • -Chronic Kidney Disease
  • -Chronic Liver Disease patients
  • -Patients on Chemotherapy
  • -Post Lung transplant
  • -History of significant bleeding -post operative or trauma
  • -History of severe epistaxis, GI bleed, hematuria, menorrhagia, petechiae,
  • -Treatment with Anticoagulants
  • -Patients in sepsis with shock or disseminated intravascular coagulation
  • -Patients with low respiratory reserve
  • -All patients who do not consent to the study

研究者

发起方
Fluid Research Fund

相似试验

To study the severity of bleeding during... | 临床试验